http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012155786-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012155786-A
titleOfInvention COMPOUND POSSESSING AN INHIBITING ACTION REGARDING PHOSPHODESTHESIS TYPE 5, AND METHOD FOR PRODUCING IT
abstract 1. The compound of formula I or its pharmaceutically acceptable salts: where the chemical name of the compound of formula I is: 5- [2-ethoxyphenyl-5- (3,4,5-trimethylpiperazinyl) sulfonyl] -1-methyl-3-propyl- 1,6-dihydro-7H-pyrazolo [4,3-a] pyrimidin-7-ketone. 2. The compound is 5- [2-ethoxyphenyl-5- (3,4,5-trimethylpiperazinyl) sulfonyl] -1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo [4,3-] pyrimidine -7-ketone citrate of formula II: .3. A process for preparing a compound of formula I comprising the following steps: (1) adding tetrahydrofuran to 2,6-dimethylpiperazine and ditretbutyl dicarbonate and reacting at room temperature, and then concentrating tetrahydrofuran until all is consumed, to give 3,5-dimethyl-1-tert β-butoxycarbonylpiperazine; (2) adding tetrahydrofuran, potassium carbonate and methyl iodide to 3,5-dimethyl-1-tert-butoxycarbonylpiperazine, obtained in turn in step (1), reacting at room temperature overnight, then filtering I and concentration, adding water and dichloromethane to the residue, washing with dichloromethane, combining the organic layer, washing with saturated brine, drying over anhydrous sodium sulfate, concentration, and column chromatography of the residue (methanol: dichloromethane = 1:20) to obtain 3.4.5 trimethyl-1-tert-butylcarbonylpiperazidine; (3) dissolving the 3,4,5-trimethyl-1-tert-butylcarbonylpiperazidine obtained in step (2) in dioxane, cooling and slowly dropwise adding a saturated solution of hydrochloric acid in dioxane with stirring at room temperature, and then evaporating the solvent under reduced pressure to obtain 1,2,6-trimethylpiperazine; (4) adding
priorityDate 2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410490687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409443016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420927256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21973747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414727158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22219990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15238643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419736107

Total number of triples: 63.